Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Small cancer risk connected to CT scans in childhood
(June 8, 2012 - Insidermedicine) From the UK - CT ...
(June 8, 2012 - Insidermedicine) From the UK - CT scans in children raises risk of cancer, according to a report published in the Lancet. Researchers examined nearly 180,000 child and adolescent patients who underwent a CT scan. They found that the scans were associated with a 3x increased risk of brain cancer and leukaemia, though the overall risk was still very low.
-
HD
Child CT scans linked to brain cancer, leukemia; Kids in the city more likely to have food allergies; Quitting smoking may be easier with healthy diet
(June 8, 2012 - Insidermedicine) From the UK - CT ...
(June 8, 2012 - Insidermedicine) From the UK - CT scans in children raises risk of cancer, according to a report published in the Lancet. Researchers examined nearly 180,000 child and adolescent patients who underwent a CT scan. They found that the scans were associated with a 3x increased risk of brain cancer and leukaemia, though the overall risk was still very low. From Chicago - Children who live in cities are more likely to have food allergies than those who live in rural areas, according to a report published in Clinical Pediatrics. Studying nearly 40,000 children under the age of 18, researchers found that nearly 10% of those living in urban areas had food allergies while only 6% of those living in rural areas had food allergies. From Buffalo - Fruits and vegetables may help smokers quit, according to a report published in Nicotine and Tobacco Research. Studying 1,000 smokers for 14 months, researchers found that those who ate the most fruits and vegetables were 3x more likely to be tobacco-free for at least a month when compared to those who ate the least.
-
HD
The importance of reducing hip fractures before population ages
(June 7, 2012 - Insidermedicine) From California - Research presented ...
(June 7, 2012 - Insidermedicine) From California - Research presented at the European League Against Rheumatism annual congress finds a majority of osteoporotic hip fractures in the US occur among the extreme elderly. Analyzing national data, researchers found that 67% of osteoporotic hip fractures in 2008 occurred among individuals over the age of 80. These results emphasize the importance of limiting fractures as the elderly population ages.
-
HD
USA, Brazil among nations with highest preterm birth rates
(June 7, 2012 - Insidermedicine) From South Africa - Preterm ...
(June 7, 2012 - Insidermedicine) From South Africa - Preterm births have dropped in only 3 countries in the past twenty years, according to a report published in the Lancet. Studying data on nearly 190 countries from 1990-2010, researchers found that premature birth rates either increased or remained the same in all but 3 countries. USA and Brazil both ranked in the top 10 countries with the highest preterm births--illustrating that the problem is not isolated to poorer countries
-
HD
Medication reduces cardiovascular events in RA patients; Rates of preterm birth rise around the world; Two thirds of hip fractures occur in people over 80
(June 7, 2012 - Insidermedicine) From the Netherlands - Treating ...
(June 7, 2012 - Insidermedicine) From the Netherlands - Treating rheumatoid arthritis patients with anti-TNF medications significantly reduces their risk of heart attack and stroke, according to a report presented at the annual congress of the European League Against Rheumatism. Studying nearly 110,000 RA patients, researchers found that one year of treatment with anti-TNF drugs reduced risk of cardiovascular events by 24%, by 42% for two years of treatment, and by 56% for three years. From South Africa - Preterm births have dropped in only 3 countries in the past twenty years, according to a report published in the Lancet. Studying data on nearly 190 countries from 1990-2010, researchers found that premature birth rates either increased or remained the same in all but 3 countries. USA and Brazil both ranked in the top 10 countries with the highest preterm births--illustrating that the problem is not isolated to poorer countries. From California - Research presented at the European League Against Rheumatism annual congress finds a majority of osteoporotic hip fractures in the US occur among the extreme elderly. Analyzing national data, researchers found that 67% of osteoporotic hip fractures in 2008 occurred among individuals over the age of 80. These results emphasize the importance of limiting fractures as the elderly population ages.
-
HD
No crime increase attributable to medical marijuana outlets around Sacramento
(June 6, 2012 - Insidermedicine) From California - Research published ...
(June 6, 2012 - Insidermedicine) From California - Research published in the Journal of Studies on Alcohol and Drugs finds no connection between medical marijuana outlets and crime. Researchers studied crime rates of 95 areas surrounding various medical marijuana outlets, finding no correlation between the presence of the outlets and increased incidence of violent crime or property crime
-
HD
Vismodegib trial stopped early due to overwhelming success
(June 6, 2012 - Insidermedicine) Dr. Jean Tang MD, PhD ...
(June 6, 2012 - Insidermedicine) Dr. Jean Tang MD, PhD from Stanford University discusses her recent study in which the new drug Vismodegib was found to both prevent and treat basal cell carcinoma in individuals at with basal cell nevus syndrome. From California - A new drug helps prevent and treat basal cell carcinoma in individuals with a rare disease, according to a report published in the NEJM. Researchers from Stanford University randomized 41 patients with Gorlin's syndrome to take daily vismodegib or placebo. The study was stopped early and all patients were given the drug due to the overwhelming effectiveness of vismodegib in both preventing and treating the development of BCC tumours.
-
HD
Fetal genome map may enable non-invasive screening of unborn child
(June 6, 2012 - Insidermedicine) From Washington - Scientists have ...
(June 6, 2012 - Insidermedicine) From Washington - Scientists have mapped the genome in a fetus with a breakthrough non-invasive technique, according to a report published in Science Translational Medicine. Researchers from the University of Washington successfully sequenced a fetus' genome using a blood sample from the mother at 18 weeks gestation and a saliva sample from the father. These results could allow doctors to screen pregnancies for thousands of disorders without going into the fetus' protective sac
-
HD
Scientists map DNA of fetus with breakthrough non-invasive technique; New drug prevents and treats skin cancer; No crime connected to medical marijuana outlets
(June 6, 2012 - Insidermedicine) From Washington - Scientists have ...
(June 6, 2012 - Insidermedicine) From Washington - Scientists have mapped the genome in a fetus with a breakthrough non-invasive technique, according to a report published in Science Translational Medicine. Researchers from the University of Washington successfully sequenced a fetus' genome using a blood sample from the mother at 18 weeks gestation and a saliva sample from the father. These results could allow doctors to screen pregnancies for thousands of disorders without going into the fetus' protective sac. From California - A new drug helps prevent and treat basal cell carcinoma in individuals with a rare disease, according to a report published in the NEJM. Researchers from Stanford University randomized 41 patients with Gorlin's syndrome to take daily vismodegib or placebo. The study was stopped early and all patients were given the drug due to the overwhelming effectiveness of vismodegib in both preventing and treating the development of BCC tumours. From California - Research published in the Journal of Studies on Alcohol and Drugs finds no connection between medical marijuana outlets and crime. Researchers studied crime rates of 95 areas surrounding various medical marijuana outlets, finding no correlation between the presence of the outlets and increased incidence of violent crime or property crime.
-
HD
Circulating cancer cells worsen survival in early breast cancer patients
(June 5, 2012 - Insidermedicine) From Texas - Research published ...
(June 5, 2012 - Insidermedicine) From Texas - Research published in the Lancet Oncology identifies a biomarker that may help predict survival in early stage breast cancer patients. Studying 302 patients with operable breast cancer, researchers found that presence of circulating cancer cells (CTCs) in the blood accurately predicted worse overall survival.
